Similar articles

• Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.

  Kawai N, Ikematsu H, Iwaki N, Maeda T, Kawashima T, Hirotsu N, Kashiwagi S. Kawai N, et al. Clin Infect Dis. 2009 Apr 1;48(7):996-7. doi: 10.1086/597360. Clin Infect Dis. 2009. PMID: 19260819 No abstract available.
• Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

  Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S. Kawai N, et al. Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424. Clin Infect Dis. 2009. PMID: 19911968
• Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.

  Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H. Shobugawa Y, et al. J Infect Chemother. 2012 Dec;18(6):858-64. doi: 10.1007/s10156-012-0428-1. Epub 2012 May 29. J Infect Chemother. 2012. PMID: 22644080 Clinical Trial.
• Antiviral drugs for influenza 2013-2014.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2014 Jan 20;56(1434):6-8. Med Lett Drugs Ther. 2014. PMID: 24457560 Review. No abstract available.
• The use of antiviral agents for the management of severe influenza.

  Smith JR, Ariano RE, Toovey S. Smith JR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.